Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program

The Changing Landscape for Stroke Prevention in AF

(2017) Menno V. Huisman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial

(2017) Dragos Vinereanu et al.   LANCET

Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation

(2016) Zardasht Oqab et al.   CANADIAN JOURNAL OF CARDIOLOGY

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

(2016) Laurent Macle et al.   CANADIAN JOURNAL OF CARDIOLOGY

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

(2016) A John Camm et al.   HEART

Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke

(2016) Jonathan C. Hsu et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives

(2016) Jonathan C. Hsu et al.   Journal of the American Heart Association

Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk

(2016) Jonathan C. Hsu et al.   JAMA Cardiology

Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II

(2015) Menno V. Huisman et al.   AMERICAN JOURNAL OF MEDICINE

Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and BleedingCLINICAL PERSPECTIVE

(2015) Peter Brønnum Nielsen et al.   CIRCULATION

Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage

(2015) Joji B. Kuramatsu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation

(2015) Kensuke Takabayashi et al.   STROKE

Prior History of Falls and Risk of Outcomes in Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project

(2014) Amitava Banerjee et al.   AMERICAN JOURNAL OF MEDICINE

Modern Management of Atrial Fibrillation Requires Initial Identification of “Low-Risk” Patients Using the CHA2DS2-VASc Score, and Not Focusing on “High-Risk” Prediction

(2014) Gregory YH Lip et al.   CIRCULATION JOURNAL

Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation

(2014) Gregory Y.H. Lip et al.   EUROPACE

Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES

(2014) T. Vanassche et al.   EUROPEAN HEART JOURNAL

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation

(2013) Menno V. Huisman et al.   AMERICAN HEART JOURNAL

Use and Associated Risks of Concomitant Aspirin Therapy With Oral Anticoagulation in Patients With Atrial Fibrillation

(2013) Benjamin A. Steinberg et al.   CIRCULATION

Worldwide Epidemiology of Atrial Fibrillation

(2013) Sumeet S. Chugh et al.   CIRCULATION

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF)

(2013) Paulus Kirchhof et al.   EUROPACE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of oral anticoagulants in atrial fibrillation is highly variable and only weakly associated with estimated stroke risk: Cross-sectional population database study

(2013) Tobias Dreischulte et al.   European Journal of General Practice

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients

(2011) Matthew B. Sellers et al.   AMERICAN HEART JOURNAL

Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation

(2011) David Conen   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improving Stroke Risk Stratification Using the CHADS 2 and CHA 2 DS 2 -VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia Burden Monitoring

(2011) Giuseppe Boriani et al.   STROKE

Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

(2011) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE